Tailoring Adjuvant Chemotherapy to Biologic Response Following Neoadjuvant Chemotherapy Impacts Overall Survival in Pancreatic Cancer

被引:0
|
作者
Elie M. Ghabi
Sami Shoucair
Ding Ding
Ammar A. Javed
Elizabeth D. Thompson
Lei Zheng
John L. Cameron
Christopher L. Wolfgang
Christopher R. Shubert
Kelly J. Lafaro
Richard A. Burkhart
William R. Burns
Jin He
机构
[1] Johns Hopkins University School of Medicine,Department of Surgery
[2] NYU Langone Health,Department of Surgery
[3] Johns Hopkins University School of Medicine,Department of Pathology
[4] Johns Hopkins University School of Medicine,Department of Oncology
来源
关键词
Neoadjuvant chemotherapy; Biologic response; Pathologic response; Pancreatic ductal adenocarcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:691 / 700
页数:9
相关论文
共 50 条
  • [31] Pathological Response and Adjuvant Chemotherapy are Prognostic Factors for Relapse Free Survival After Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer With Arterial Involvement
    Saito, K.
    Nakai, Y.
    Arita, J.
    Kazunaga, I.
    Takahara, N.
    Hasegawa, K.
    Koike, K.
    PANCREAS, 2019, 48 (10) : 1513 - 1514
  • [32] Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology
    Elizabeth J. Olecki
    Kelly A. Stahl
    Madeline B. Torres
    June S. Peng
    Matthew Dixon
    Chan Shen
    Niraj J. Gusani
    Annals of Surgical Oncology, 2021, 28 : 3111 - 3122
  • [33] Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology
    Olecki, Elizabeth J.
    Stahl, Kelly A.
    Torres, Madeline B.
    Peng, June S.
    Dixon, Matthew
    Shen, Chan
    Gusani, Niraj J.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3111 - 3122
  • [34] Multiagent neoadjuvant chemotherapy and tumor response are associated with improved survival in pancreatic cancer
    Bolton, Nathan M.
    Maerz, Adam H.
    Brown, Russell E.
    Bansal, Mona
    Bolton, John S.
    Conway, William C.
    HPB, 2019, 21 (04) : 413 - 418
  • [35] In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
    Hao, Zhonglin
    Chen, Quan
    Huang, Bin
    ONCOLOGIST, 2023, 28 (07): : E590 - E590
  • [36] Adjuvant Chemotherapy Is Not Guided by Pathologic Treatment Effect After Neoadjuvant Chemotherapy in Pancreatic Cancer
    Gleeson, Elizabeth M.
    Leigh, Natasha
    Golas, Benjamin J.
    Magge, Deepa
    Sarpel, Umut
    Hiotis, Spiros P.
    Labow, Daniel M.
    Pintova, Sofya
    Cohen, Noah A.
    PANCREAS, 2021, 50 (08) : 1163 - 1168
  • [37] Impact on overall survival and disease-free survival of adjuvant chemotherapy after neoadjuvant chemoradiotherapy for rectal cancer
    de Castro, Rafael Amaral
    Paiva, Carlos Eduardo
    Saad-Hossne, Rogerio
    Michelin, Odair Carlito
    Souza, Cristiano de Padua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy
    Franklin, Oskar
    Sugawara, Toshitaka
    Ross, Richard Blake
    Franco, Salvador Rodriguez
    Colborn, Kathryn
    Karam, Sana
    Schulick, Richard D.
    Del Chiaro, Marco
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 4966 - 4975
  • [39] ASO Visual Abstract: Neoadjuvant Gastric Score—How Response to Neoadjuvant Chemotherapy Affects Overall Survival and Adjuvant Benefit
    Chase J. Wehrle
    Caleb N. Seavey
    Jenny Chang
    Katherine Stackhouse
    Kimberly Woo
    Toms Augustin
    Daniel Joyce
    Robert Simon
    R. Matthew Walsh
    Samer A. Naffouje
    Annals of Surgical Oncology, 2023, 30 : 8607 - 8608
  • [40] Metastasis-free Survival and Overall Survival in Patients with Metaplastic Breast Carcinoma treated with Adjuvant Chemotherapy or Neoadjuvant Chemotherapy
    Xu, Jiawen
    Gao, Yuan
    Liu, Yi
    Hou, Yanjun
    Zhang, Huina
    Guo, Hua
    Peng, Limin
    Wei, Shi
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2024, 104 (03) : S310 - S311